Home
Conditions
Myelodysplastic Syndromes

Clinical trial condition

Myelodysplastic Syndromes

Explore clinical trials studying Myelodysplastic Syndromes. Study availability and eligibility vary by location and protocol.

1,362 public trials 239 recruiting studies

Refine in advanced search Browse all conditions

Myelodysplastic Syndromes trial results

Completed

Chemotherapy, Radiation Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer

NCT00005092

Conditions: Blast Crisis, Blood Protein Disorders, Bone Marrow Diseases, +77 more
Locations: University of Illinois at Chicago Chicago, Illinois, United States

Washington University Barnard Cancer Center St Louis, Missouri, United States

University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Amifostine in Treating Patients With Myelodysplastic Syndrome

NCT00003048

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +1 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

MRI Screening for Patients With Myelodysplastic Syndrome (MDS), Who Have Received Multiple Red Blood Cell Transfusions

NCT00749372

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations: Weill Medical College of Cornell University New York, United States

View Trial Details

Completed

Dolastatin 10 in Treating Patients With Refractory or Relapsed Acute Leukemia, Myelodysplastic Syndrome, or Chronic Myelogenous Leukemia

NCT00003693

Conditions: Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +27 more
Locations: University of Texas - MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Low Dose Melphalan and Bortezomib for AML and High-Risk MDS

NCT00789256

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations: Integrated Community Oncology Network Jacksonville, Florida, United States

Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

View Trial Details

Completed

Determination of Safe and Effective Dose of Romiplostim (AMG 531) in Subjects With Myelodysplastic Syndrome (MDS)Receiving Hypomethylating Agents

NCT00321711

Conditions: Blood Platelet Disorders, Bone Marrow Diseases, Cytopenia, +5 more
Locations: Not specified

View Trial Details

Completed

Shorter Course Tacrolimus After Nonmyeloablative, Related Donor BMT With High-dose Posttransplantation Cyclophosphamide

NCT01342289

Conditions: Blood Protein Disorders, Bone Marrow Diseases, Cardiovascular Diseases, +22 more
Locations: Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS

NCT02732184

Conditions: Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: Comprehensive Cancer Center at University of Michigan Ann Arbor, Michigan, United States

Washington University Medical School St Louis, Missouri, United States

University Hospitals Case Medical Center Cleveland, Ohio, United States

The Cleveland Clinic Cleveland, Ohio, United States

View Trial Details

Completed

PKC412 and 5-Azacytidine

NCT01202877

Conditions: Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +6 more
Locations: University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Phase I, Dose Escalation Study of Decitabine

NCT02264873

Conditions: Bone Marrow Diseases, Disease Attributes, Hematologic Diseases, +19 more
Locations: UF Health Shands Hospital Gainesville, Florida, United States

View Trial Details

Myelodysplastic Syndromes

Myelodysplastic Syndromes trial results

Related conditions